RAPT vs. ATMU

Last updated Jun 3, 2026

RAPT (RAPT Therapeutics, Inc.) and ATMU (Atmus Filtration Technologies Inc.) are both stocks. RAPT operates in Biotechnology (Healthcare), while ATMU operates in Pollution & Treatment Controls (Industrials). At a 0.12 correlation, their price movements are largely independent.

Performance

RAPT vs. ATMU - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in RAPT Therapeutics, Inc. (RAPT) and Atmus Filtration Technologies Inc. (ATMU). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

RAPT

• 1D: —
• 1M: —
• YTD: —
• 6M: —
• 1Y: —
• 3Y*: —
• 5Y*: —
• 10Y*: —

ATMU

• 1D: 3.39%
• 1M: -10.16%
• YTD: -8.80%
• 6M: -9.43%
• 1Y: 31.28%
• 3Y*: 32.34%
• 5Y*: —
• 10Y*: —

*Multi-year figures are annualized to reflect compound growth (CAGR)

RAPT vs. ATMU - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023
RAPT RAPT Therapeutics, Inc.	71.30%	167.96%	-93.64%	22.11%
ATMU Atmus Filtration Technologies Inc.	-8.80%	33.16%	67.28%	8.50%

Correlation

The correlation between RAPT and ATMU is 0.04, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.04
Correlation (3Y) Calculated over the trailing 3-year period	0.12
Correlation (All Time) Calculated using the full available price history since May 30, 2023	0.12

Fundamentals

Market Cap RAPT : $1.56B ATMU : $3.87B
EPS RAPT : -$3.92 ATMU : $2.56
PB Ratio RAPT : 10.29 ATMU : 9.60
Total Revenue (TTM) RAPT : $0.00 ATMU : $1.35B
Gross Profit (TTM) RAPT : -$200.00K ATMU : $529.00M
EBITDA (TTM) RAPT : -$108.01M ATMU : $334.60M

Return for Risk

RAPT vs. ATMU — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

ATMU

ATMU Risk / Return Rank: 64
ATMU Sharpe Ratio Rank: 68
ATMU Sortino Ratio Rank: 60
ATMU Omega Ratio Rank: 62
ATMU Calmar Ratio Rank: 62
ATMU Martin Ratio Rank: 71

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

RAPT vs. ATMU - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for RAPT Therapeutics, Inc. (RAPT) and Atmus Filtration Technologies Inc. (ATMU). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Risk / return metrics aren't available yet — we need at least 12 months of trading data to calculate them.

Sharpe Ratios by Period

	RAPT	ATMU	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	—	0.88	—
Sharpe Ratio (All Time) Calculated using the full available price history	—	0.88	—

Drawdowns

Drawdown Indicators

	RAPT	ATMU	Difference
Max Drawdown Largest peak-to-trough decline	—	-30.22%	—
Max Drawdown (1Y) Largest decline over 1 year	—	-30.22%	—
Max Drawdown (3Y) Largest decline over 3 years	—	-30.22%	—
Current Drawdown Current decline from peak	—	-27.86%	—
Average Drawdown Average peak-to-trough decline	—	-8.48%	—
Ulcer Index Depth and duration of drawdowns from previous peaks	—	8.04%	—

Volatility

Volatility by Period

	RAPT	ATMU	Difference
Volatility (1M) Calculated over the trailing 1-month period	—	12.27%	—
Volatility (6M) Calculated over the trailing 6-month period	—	30.47%	—
Volatility (1Y) Calculated over the trailing 1-year period	—	35.82%	—
Volatility (5Y) Calculated over the trailing 5-year period, annualized	—	34.44%	—
Volatility (10Y) Calculated over the trailing 10-year period, annualized	—	34.44%	—

Dividends

RAPT vs. ATMU - Dividend Comparison

RAPT has not paid dividends to shareholders, while ATMU's dividend yield for the trailing twelve months is around 0.57%.

Position	TTM	2025	2024
ATMU Atmus Filtration Technologies Inc.	0.47%	0.40%	0.26%
RAPT RAPT Therapeutics, Inc.	0.00%	0.00%	0.00%

Financials

Frequently Asked Questions

Can I hold both RAPT and ATMU in my portfolio?

RAPT and ATMU have a correlation of 0.04, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.